Virax Biolabs Debuts ImmuneSelect Portfolio

TipRanksApr 25 08:58 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC

BenzingaApr 25 08:06 ET

Express News | EXCLUSIVE: Virax Biolabs Tells Benzinga 'The Launch Marks a Significant Milestone for Virax as It Brings Us a Step Closer to Commercializing ViraxImmuneTM as a Full In-Vitro-Diagnostic Product'

BenzingaApr 25 07:52 ET

Express News | EXCLUSIVE: Virax Biolabs Tells Benzinga Co. Launches Portfolio Of Immune Profiling Solutions Evaluating Adaptive Immunity In Post-Viral Syndromes

BenzingaApr 25 07:51 ET

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes

Thursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching 'ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society of C

BenzingaApr 25 07:45 ET

Virax Biolabs Showcases Innovations at ESCMID 2024

TipRanksApr 16 07:57 ET